Allergy This medicine is not recommended for use in patients with a known allergy to Levocarnitine, Vitamin E or any other inactive ingredients present along with the formulation
Some laboratory studies suggest GLP-1 may modulate inflammatory pathways relevant to psoriasis, including reducing pro-inflammatory cytokines such as tumour necrosis factor-alpha (TNF-) and interleukin-17 (IL-17)
Schedule your consultation today and take the first step toward lasting wellness!
The genuine frontier in this field is combining GLP-1 with other metabolic hormones, such as GIP (already done in tirzepatide) and glucagon, not adding GLP-2
High Dose (80-120+ mcg/day): Doses exceeding 80mcg per day are typically reserved for short-term, highly specific, and advanced research protocols
Berberine should be avoided during pregnancy and breastfeeding due to insufficient safety data